Navigation Links
Update on Astellas' Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications
Date:8/12/2009

DEERFIELD, Ill., Aug. 12 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") announced today an update regarding the status of the request for emergency relief and preliminary injunction from the U.S. Food and Drug Administration's (FDA) decision regarding its Citizen Petition. The company's requests have been denied by the U.S. District Court in Washington, D.C. The company is disappointed in the court's decision and is currently evaluating its next course of action.

The Citizen Petition requested that the FDA ensure the safe and effective use of immunosuppressants (also called anti-rejection medications) used to prevent rejection in organ transplant patients. The petition sought additional measures from the FDA to protect transplant recipients from substitute critical dose immunosuppressant drugs that have not demonstrated bioequivalence in rigorous clinical trials in transplant patients. On August 10, 2009, the FDA substantially denied the Citizen Petition and approved an Abbreviated New Drug Application (ANDA) for generic tacrolimus. On August 11, 2009, Astellas requested the U.S. District Court in D.C. to issue a temporary restraining order enjoining the FDA's approval of the ANDA for tacrolimus.

"As a leader in the field of transplantation, Astellas remains firmly committed in our efforts to providing appropriate care as well as safe and effective treatments for this unique and vulnerable patient population," said William E. Fitzsimmons, Pharm.D., M.S., Senior Vice President, Development. "We are disappointed in the decision of the judge to not grant emergency relief, and are evaluating all options available to us."

About Organ Transplantation

There are nearly 100,000 patients on the waiting list for an organ transplant and 4,000 patients are added to the list each month. Each day, on average, seventeen patients on the list die waitin
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Nutrition 21 Announces Preliminary Fourth Quarter Financial Update Also Announces Negotiations on Notes due August 25, 2009
2. China Pharma Holdings, Inc. Reports Second Quarter 2009 Financial Results and Corporate Updates
3. Video: Provectus Pharmaceuticals Updates Shareholders On 2009 Year-To-Date Accomplishments
4. GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
5. Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance
6. Air Methods Reports 2Q2009 Results and 3Q2009 Update
7. NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions
8. Decision Resources Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals Fostamatinib Disodium
9. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Second Quarter Ended June 30, 2009 and to Provide a Business Update
10. NCCN Updates Infection Guidelines to Include Information About H1N1 Virus (Swine Flu)
11. BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Rosa, CA (PRWEB) December 19, 2014 ... and 5x5 SuperClone Rooms. SuperCloset continues to offer indoor ... solutions. Pair one of the new SuperClone Rooms with ... professional, perpetual, and turnkey indoor hydroponic grow room setup. ... in the world, SuperCloset’s SuperPonic SuperCloner 50 . ...
(Date:12/19/2014)... These vanadium reserves are mostly found in ... tons of vanadium were produced globally in 2013, up ... at 6.7% AAGR during the period from 2001 to ... the largest consumer, accounted for more than 90% of ... and the chemical industry. , View Full Report at ...
(Date:12/19/2014)... (PRWEB) December 20, 2014 The Medspa ... new injectable filler from respected cosmetic brand Juvéderm. Voluma ... naturally with age. The Medspa at Hendrick is pleased ... in skin care technology to its clients. , Voluma ... to be FDA-approved to treat the mid-face and cheek ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- New research warns parents that buying ... at risk. Nearly half of teen drivers killed in the ... at least 11 years old and often lacked important safety features ... percent of teen drivers killed in crashes were in cars at ... 10 years old, 31 percent were in cars 11 to 15 ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- All children should have ... 6, preferably every year, eye experts say. The ... expert panel of the U.S. National Center for Children,s ... this age group require screening for eye problems, particularly ... as amblyopia ("lazy eye") and strabismus (a disorder of ...
Breaking Medicine News(10 mins):Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Preschoolers Need Eye Screening, Experts Say 2
... ... year old Mitchell Brown ( www.helpmitchell.com ), an athlete, loving young father, and lifetime resident of ... months before the birth of his second child. , ... East Brunswick, NJ (Vocus) September 3, 2009 -- The race is on to find ...
... goal, researchers say , THURSDAY, Sept. 3 (HealthDay News) -- ... to cooperate, researchers at Harvard University and the Stockholm School ... a stick. , In certain situations "where people interact ... our work suggests that rewards result in better outcomes than ...
... , BROOMFIELD, Colo., Sept. 3 Embla(R) and ... acquire Covidien,s Sleep Diagnostic business. This includes the sleep diagnostic products ... transaction were not disclosed. Completion of the sale is subject to ... will form the world,s largest company to focus entirely on sleep ...
... Unanimous Decision on Med Mal, Negligence, and TAPA Claims , ... favor of the estate of Mrs. Voncil Sherrod, who died on 3/24/05 ... Rehabilitation, a Mariner Health Care nursing home in Tennessee. Counsel for ... of the firm Marks, Balette & Giessel, P.C. and Matthew Mussalli. , ...
... China, Sept. 3 /PRNewswire-FirstCall/ - Hard to Treat Diseases (the ... D, Rule 504 offering and is no longer selling shares ... will be filed with the Securities and Exchange Commission shortly, ... over the past twelve months. The limit to any such ...
... Ga., Sept. 3 Aflac Incorporated (NYSE: AFL ) ... Bruyette, & Woods 2009 Insurance Conference. Chairman and Chief Executive ... scheduled to make a presentation on September 10, 2009, at 2:05 ... discuss the company,s outlook for 2009 and its strategy for growth ...
Cached Medicine News:Health News:Jewish Stem Cell Donor Urgently Sought for Young NJ Man Battling Aggressive Non-Hodgkin Lymphoma 2Health News:Jewish Stem Cell Donor Urgently Sought for Young NJ Man Battling Aggressive Non-Hodgkin Lymphoma 3Health News:Rewards Are Key to Cooperation 2Health News:Embla(R) Systems Announces the Acquisition of the Sandman(R) Sleep Diagnostic Business from Covidien(R) - Creating the World's Largest Sleep Diagnostic Company 2Health News:Arbitration Panel Finds in Favor of Tennessee Victim of Mariner Nursing Home Negligence 2Health News:Hard To Treat Diseases (HTDS) to Retire Regulation D 504 Offering 2Health News:Hard To Treat Diseases (HTDS) to Retire Regulation D 504 Offering 3Health News:Aflac Incorporated To Present at the Keefe, Bruyette & Woods 2009 Insurance Conference 2
(Date:12/19/2014)... YORK , Dec. 18, 2014 Somewhere ... addressing hearing health was forgotten. But Audicus , ... to hear better this new year. Hearing ... facing the aging population, though it is often unaddressed. ... in four has a hearing aid, mainly due to ...
(Date:12/19/2014)... , Dec. 18, 2014  Decision Resources Group ... the United States will increase to a ... be primarily driven by expansion in the large direct ... devices will be increasingly adopted due to the advantages ... Other key findings from Decision Resources Group,s coverage ...
(Date:12/19/2014)... Ky. , Dec. 18, 2014 Baptist Health ... States to receive full Atrial Fibrillation with Electrophysiology ... Care (SCPC). Atrial fibrillation is the most common ... that in some cases can lead to stroke and possible ... United States have atrial fibrillation and the numbers ...
Breaking Medicine Technology:Audicus Will Help People Resolve to Hear Better in 2015 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3
... , INDIANAPOLIS, Aug. 10 Acquire ... fabrication and integration and automation services, has recently expanded ... in its focus on a long-term goal of becoming ... North America. , , Acquire Automation ...
... SEATTLE, Aug. 7 Regular yoga practice is associated ... to be obese, according to a study led by researchers at ... study was prompted by initial findings reported four years ago by ... may help prevent middle-age spread in normal-weight people and may promote ...
Cached Medicine Technology:Vision Inspection Systems Specialist Acquire Automation Expands Employee Base, Launches New Web Site 2Regular Yoga Practice Is Associated With Mindful Eating 2Regular Yoga Practice Is Associated With Mindful Eating 3Regular Yoga Practice Is Associated With Mindful Eating 4
... Used for stone manipulation and removal in ... the basket to retain its shape following extreme ... stone capture by allowing the basket to open ... the stone. The tipless design reduces the likelihood ...
... Perc NCircle® is designed to provide rapid ... The Perc NCircle combines traditional surgical instrument ... tipless basket technology. The small, flexible ... allows the surgeon to remove larger stones ...
... Used for temporary internal drainage ... bladder. Supplied sterile in peel-open packages. ... evaluation is advised; C-Flex® and Sof-Flex® ... than six (6) months; silicone stents ...
... ACMI Classic Double Pigtail Ureteral ... pigtail design that maximizes migration. They ... added versatility and cost savings. ... Kit contains one Classic Double PigTail ...
Medicine Products: